Noninvasive ventilation in acute care: controversies and emerging concepts.
This conference brought together experts on noninvasive ventilation (NIV) to discuss and debate the advances in evidence and technology over the past decade. A major impetus for the conference was that many institutions have not systematically integrated NIV into their clinical practice, despite mou...
| Publicado en: | Respiratory Care Vol. 54; no. 2; pp. 259 - 264 |
|---|---|
| Autor principal: | |
| Formato: | Journal Article |
| Publicado: |
Mary Ann Liebert, Inc.
Feb2009
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=105451048&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 105451048 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 00201324 4GG jtl: Respiratory Care issn: 00201324 maglogo: N pubinfo: dt: Feb2009 vid: 54 iid: 2 pid: 1365 pub: Mary Ann Liebert, Inc. place: New Rochelle, New York artinfo: ui: 105451048 2010192198 NLM19173757 105451048 ppf: 259 ppct: 5 formats: fmt: @attributes: type: P tig: atl: Noninvasive ventilation in acute care: controversies and emerging concepts. aug: au: Kallet RH affil: Respiratory Care Services, San Francisco General Hospital, NH:GA-2, 1001 Potrero Avenue, San Francisco CA 94110. rkallet@sfghsom.ucsf.edu. sug: subj: Respiration, Artificial Methods Respiratory Failure Therapy Acute Care Positive Pressure Ventilation Respiration, Artificial Utilization ab: This conference brought together experts on noninvasive ventilation (NIV) to discuss and debate the advances in evidence and technology over the past decade. A major impetus for the conference was that many institutions have not systematically integrated NIV into their clinical practice, despite mounting, high-level evidence supporting its effectiveness. NIV clearly improves outcomes for patients with chronic obstructive pulmonary disease and acute cardiogenic pulmonary edema when instituted as a first-line therapy. Although the evidence is less persuasive, initial intervention with NIV also might benefit a carefully selected subset of patients with acute lung injury, as well as those with acute respiratory failure who are immunocompromised. The papers in this and last month's special issue of the Journal provide an informative guide for clinicians attempting to implement NIV in their institutions. This paper summarizes the major findings from each presentation and the discussions that followed. pubtype: Academic Journal doctype: Journal Article ougenre: Article language: English refInfo: holdings: @attributes: islocal: N |
|---|